After cataract surgery, some patients experience dysphotopsias. Why? Plus, how to manage these patients.
Explore TEPEZZA® (teprotumumab-trbw) now for your patients with this serious, progressive disease.
TEPEZZA is a trademark owned by or licensed to Horizon.© 2022 Horizon Therapeutics plc P-TEP-US-00805 12/22
Public & Patients
Museum of the Eye